By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous uncategorized agents > Hylenex > Hyaluronidase Dosage
Miscellaneous uncategorized agents
https://themeditary.com/dosage-information/hyaluronidase-dosage-2874.html

Hyaluronidase Dosage

Drug Detail:Hylenex (Hyaluronidase (injection) [ hye-al-ure-on-i-dase ])

Drug Class: Miscellaneous uncategorized agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Hypodermoclysis

After inserting the needle, begin clysis with tip of needle lying free and movable between the skin and muscle. The fluid should start in readily without pain or lump. Then hyaluronidase should be injected into the rubber tubing close to the needle.

Alternate method: Inject hyaluronidase under skin before clysis. 150 to 200 units will facilitate absorption of 1000 mL or more of solution.

Comments:

  • The dose, rate of injection, and type of solution should be individualized; rate of infusion and volume of administration should not exceed those used for intravenous infusion.
  • Hypovolemia may occur if electrolyte-free solutions are given.
  • Adding adequate quantities of electrolytes and/or controlling the volume and rate of administration will prevent hypovolemia.


Use: As an adjuvant in subcutaneous fluid administration (hypodermoclysis) for achieving hydration

Usual Adult Dose for Subcutaneous Urography

With the patient prone, inject 75 Units subcutaneously over each scapula, followed by injection of contrast medium at the same sites

Use: As an adjuvant in subcutaneous urography for improving resorption of radiopaque agents

Usual Pediatric Dose for Hypodermoclysis

After inserting the needle, begin clysis with tip of needle lying free and movable between the skin and muscle. The fluid should start in readily without pain or lump. Then hyaluronidase should be injected into the rubber tubing close to the needle.

Alternate method: Inject hyaluronidase under skin before clysis. 150 to 200 units will facilitate absorption of 1000 mL or more of solution.

Under 3 years of age:

  • Limit the volume of a single clysis to 200 mL

Premature Infants or During the Neonatal Period:
Maximum daily dosage: 25 mL/kg of body weight
Maximum rate of administration: 2 mL/minute

Comments:
  • The dose, rate of injection, and type of solution should be individualized; rate of infusion and volume of administration should not exceed those used for intravenous infusion.
  • Hypovolemia may occur if electrolyte-free solutions are given.
  • Adding adequate quantities of electrolytes and/or controlling the volume and rate of administration will prevent hypovolemia.


Use: As an adjuvant in subcutaneous fluid administration (hypodermoclysis) for achieving hydration

Usual Pediatric Dose for Subcutaneous Urography

With the patient prone, inject 75 Units subcutaneously over each scapula, followed by injection of contrast medium at the same sites

Use: As an adjuvant in subcutaneous urography for improving resorption of radiopaque agents

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to any of the ingredients

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Do not give intravenously
  • For infiltration, interstitial, intramuscular, intraocular, peribulbar, retrobulbar, soft tissue, or subcutaneous use.

Storage requirements:
  • Refrigerate; do not freeze
  • Protect from light

IV compatibility:
  • Check appropriate references for physical or chemical incompatibilities.

Frequently asked questions

  • Do Herceptin (trastuzumab) injections hurt?
Share this Article
Latest News
Medical News

Alzheimer's: HIV drugs may offer ‘significant’ protection

May 12, 2025
Gastrointestinal cancer: Can eating chicken shorten lifespan?
Shingles vaccine may lower heart disease risk by up to 8 years
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by